Evolent Health (EVH) Equity Average (2014 - 2026)

Evolent Health has reported Equity Average for 13 years, with the latest figure at $405.8 million in Q1 2026.

• For the quarter ending Q1 2026, Equity Average fell 58.1% year-over-year to $405.8 million; the trailing twelve-month figure through Mar 2026 stood at $405.8 million (down 58.1% YoY), and the FY2025 full-year result was $708.2 million, down 31.54% from the prior year.
• Equity Average for Q1 2026 stood at $405.8 million, down from $628.7 million in the prior quarter.
• The five-year high for Equity Average was $1.1 billion in Q2 2023, with the low at $405.8 million in Q1 2026.
• Average Equity Average over 5 years is $887.9 million, with a median of $968.4 million recorded in 2025.
• Year-over-year, Equity Average jumped 80.92% in 2023 and plunged 58.1% in 2026.
• Tracing EVH's Equity Average over 5 years: stood at $857.8 million in 2022, then climbed by 26.13% to $1.1 billion in 2023, then fell by 5.72% to $1.0 billion in 2024, then sank by 38.36% to $628.7 million in 2025, then slumped by 35.46% to $405.8 million in 2026.
• The last three Equity Average figures came in at $405.8 million (Q1 2026), $628.7 million (Q4 2025), and $869.1 million (Q3 2025), per Business Quant data.

Peer Comparison